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Novel biological super-luminescent sensors for the detection of neurodegenerative disorders
Florencia A. Monge
Biomedical Engineering
Alzheimer’s disease (AD) is the 6th leading cause of death in the U.S. and the only disease in the
top ten causes for which we have no treatment or cure. The cost of this disease is expected to rise
over a trillion dollars over the next 30 years, it affects individuals and it is also a national healthcare
crisis. This disease shares pathological hallmarks, protein aggregates, with other
neurodegenerative disorders such as Parkinson’s disease and traumatic brain injuries. Proteins are
an organism’s micro-machinery for transport, defense, storage, and communication. However, in
neurodegenerative diseases, the proteins malfunction, change shape, clump together and cause
damage to neurons resulting in cell death. Such protein aggregates are characterized by the
misfolding and aggregation of the amyloid beta (Ab) and tau proteins in AD. Neuronal loss occurs
decades prior to the onset of symptoms, making the pre-symptomatic stage an ideal target window
for detection and treatment. Currently, we do not have clinically useful diagnostic tools to detect
these biomarkers. Oligo phenylene ethynylenes (OPEs) are a novel class of molecular sensors with
turn-on fluorescence mechanisms. A library of OPEs includes molecules varying in lengths,
charges, and chemical groups. We have narrowed the selection down to two molecules with
opposite charges. These two OPES display high selectivity for the pathological fibrillar form of
protein versus a healthy, monomeric protein. While the molecules are non-fluorescent in water,
they become super-luminescent after binding to their target, large protein assemblies. Our idea
revolves around the application of OPEs as a non-protein specific, aggregate specific, biological
sensors for pathological protein aggregates. We have tested the selectivity and affinity of these
sensors towards protein assemblies in animal and human brain tissue with optimistic results. Due
to this, we see the potential of these small molecules as diagnostic tools for neurodegeneration or
other diseases also characterized by unhealthy protein aggregation such as systemic amyloidosis
or type II diabetes.

